Status:
UNKNOWN
rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Conditions:
Bipolar Disorder in Remission
Eligibility:
All Genders
14-45 years
Phase:
NA
Brief Summary
Based on the individualized positioning technology of diffusion tensor imaging (DTI), the purpose of this study is to explore a new stimulation target and protocol for the treatment of bipolar disorde...
Eligibility Criteria
Inclusion
- 1\. Age 14-45 years old, regardless of gender\] 2.Meet DSM-V diagnostic criteria for bipolar depressive in remission 3.Young Mania Rating Scale (YMRS) ≤ 6 points; 4.Hamilton Depression Scale(HAMD-17)≤7 points; 5.Cognitive deficit questionnaire PDQ≥17 points; 6.Han nationality, right-handed; 7.More than 9 years of education.
Exclusion
- History of severe somatic or brain organic diseases and craniocerebral trauma;
- Abnormal brain structure or any MRI contraindications were found by magnetic resonance examination;
- Those who do not cooperate or cannot effectively complete the experiment;
- Drug, alcohol or other psychoactive substance abusers;
- Pregnant, lactating or planned pregnancy;
- ECT or rTMS or tACS treatment was performed within six months.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 4 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05964777
Start Date
July 1 2023
End Date
April 4 2024
Last Update
July 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, First Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310000